Micro-X Ltd - Asset Resilience Ratio
Micro-X Ltd (MX1) has an Asset Resilience Ratio of 28.12% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Micro-X Ltd's Asset Resilience Ratio has changed over time. Check MX1 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Micro-X Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Micro-X Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$4.90 Million | 28.12% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$4.90 Million | 28.12% |
Asset Resilience Insights
- Very High Liquidity: Micro-X Ltd maintains exceptional liquid asset reserves at 28.12% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Micro-X Ltd Industry Peers by Asset Resilience Ratio
Compare Micro-X Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for Micro-X Ltd (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Micro-X Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 14.67% | AU$3.24 Million ≈ $2.29 Million |
AU$22.11 Million ≈ $15.64 Million |
+2.66pp |
| 2024-06-30 | 12.00% | AU$3.23 Million ≈ $2.28 Million |
AU$26.89 Million ≈ $19.03 Million |
-5.24pp |
| 2023-06-30 | 17.24% | AU$5.22 Million ≈ $3.70 Million |
AU$30.30 Million ≈ $21.44 Million |
-15.70pp |
| 2022-06-30 | 32.94% | AU$10.30 Million ≈ $7.29 Million |
AU$31.28 Million ≈ $22.13 Million |
-34.50pp |
| 2021-06-30 | 67.44% | AU$30.14 Million ≈ $21.32 Million |
AU$44.68 Million ≈ $31.61 Million |
+13.09pp |
| 2020-06-30 | 54.35% | AU$18.32 Million ≈ $12.96 Million |
AU$33.70 Million ≈ $23.85 Million |
+38.08pp |
| 2019-06-30 | 16.27% | AU$1.61 Million ≈ $1.14 Million |
AU$9.87 Million ≈ $6.98 Million |
-11.52pp |
| 2018-06-30 | 27.79% | AU$4.07 Million ≈ $2.88 Million |
AU$14.65 Million ≈ $10.37 Million |
+6.09pp |
| 2017-06-30 | 21.70% | AU$5.58 Million ≈ $3.95 Million |
AU$25.70 Million ≈ $18.19 Million |
-- |
About Micro-X Ltd
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or … Read more